<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://www.oncologytube.com/videoEmbed/38095/anti-egfr-resistance-mechanism-using-tumor-dna-assay-katherineclift4-wustl?channelName=5dc078e29e2c9" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

0:07:15

Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL

Name: Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
Uploaded: 2019-11-04T11:53:14
Duration: 7 min 15 s
Description: Katherine Clifton, MD @katherineclift4 of @WUSTL discusses actionable fusions as an anti-EGFR resistance mechanism. __________ Read here: https://ascopubs.org/doi/10.1200/PO.19.00141

WUSTL

10 months

48 Views

Share Report Add to 0 0

Share Video (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://www.oncologytube.com/videoEmbed/38095/anti-egfr-resistance-mechanism-using-tumor-dna-assay-katherineclift4-wustl?channelName=5dc078e29e2c9" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Share Video (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://www.oncologytube.com/videoEmbed/38095/anti-egfr-resistance-mechanism-using-tumor-dna-assay-katherineclift4-wustl?channelName=5dc078e29e2c9"></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://www.oncologytube.com/videoEmbed/38095/anti-egfr-resistance-mechanism-using-tumor-dna-assay-katherineclift4-wustl?channelName=5dc078e29e2c9" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Colorectal Cancer

Description:

Katherine Clifton, MD @katherineclift4 of @WUSTL discusses actionable fusions as an anti-EGFR resistance mechanism.

__________

Read here: https://ascopubs.org/doi/10.1200/PO.19.00141